» Articles » PMID: 30084048

MicroRNA Expression in the Affected Skin of Adult Patients with IgA Vasculitis

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2018 Aug 8
PMID 30084048
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

IgA vasculitis (IgAV) represents a common systemic vasculitis in pediatric and adult population. Our current knowledge of disease pathogenesis is still very limited, without information on miRNAs in IgAV. The aim of our study was to determine the expression of five pre-selected miRNAs (miRNA-146a-5p, miRNA-148-3p, miRNA-155-5p, miRNA-223-3p, and let-7b) in the affected skin of adult IgAV patients. The study included 65 skin samples from consecutive, untreated IgAV patients (61.5% male, median age 67.6 years, range 29-91), diagnosed between October 2014 and September 2016, and 20 samples of normal skin from healthy volunteers. Total RNA was isolated from tissue sections of formalin-fixed, paraffin-embedded samples. Expression of miRNAs was measured using qRT-PCR. To present relative miRNA expression, the ΔΔCT method was used. Skin miRNA expression was correlated to clinical characteristics of adult IgAV patients. We found significantly higher levels of miRNA-155-5p, miRNA-223-3p, and let-7b in the affected skin compared to controls (18.6-fold, 6.4-fold, and 7.9-fold higher respectively). Contrary, the miRNA 148-3p expression was significantly lower (2.2-fold). The expression of the miRNA-146-5p showed near normal levels. Patients with necrotic skin lesions had significantly higher miRNA-223 tissue expression than those with non-necrotic purpura (p = 0.029). Gastrointestinal tract involvement inversely correlated with the expression of miRNA-155-5p and/or miRNA-146a-5p in affected skin. Altered expression of miRNA-148b-3p, miRNA-155-5p, miRNA-223-3p, and let-7b was found in vasculitic skin lesions in IgAV. Additionally, we found a positive association between the severity of purpura and skin miRNA-223-3p expression. Aberrantly expressed miRNAs could represent a biomarker in adult IgAV.

Citing Articles

Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers.

Bajzelj M, Hladnik M, Blagus R, Jurcic V, Markez A, Toluay T Arthritis Res Ther. 2024; 26(1):85.

PMID: 38610060 PMC: 11010360. DOI: 10.1186/s13075-024-03317-6.


Role of microRNAs in Immune Regulation with Translational and Clinical Applications.

Gaal Z Int J Mol Sci. 2024; 25(3).

PMID: 38339220 PMC: 10856342. DOI: 10.3390/ijms25031942.


IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes.

Sugino H, Sawada Y, Nakamura M Int J Mol Sci. 2021; 22(14).

PMID: 34299162 PMC: 8307949. DOI: 10.3390/ijms22147538.

References
1.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

2.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

3.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

4.
Ozen S, Pistorio A, Iusan S, Bakkaloglu A, Herlin T, Brik R . EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69(5):798-806. DOI: 10.1136/ard.2009.116657. View

5.
Kiryluk K, Moldoveanu Z, Sanders J, Eison T, Suzuki H, Julian B . Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011; 80(1):79-87. PMC: 3641561. DOI: 10.1038/ki.2011.16. View